Investors are closely watching Eli Lilly & Company (LLY) as the pharmaceutical giant prepares to release its Q3 earnings later this week. Market watchers are predicting strong growth driven by the robust sales of Lilly's blockbuster drugs, particularly recent launches. However, there are also concerns about potential headwinds from regulatory scrut… Read More